Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Biomarkers of disease progression in progressive supranuclear palsy for use in clinical trials

Brain Communications(2024)10.1093/braincomms/fcaf022Source: DataRank Database

Biomarkers of disease progression in progressive supranuclear palsy for use in clinical trials is a research paper published in Brain Communications (2024). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (15 grants)OA: goldTopics (5)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Benjamin Sinclair ORCID,Terence J. O’Brien ORCID,Lucy Vivash ORCID,Cassandra Marotta ORCID

Live enrichment

PubMed:39882025 PMC:PMC11775610

National Health and Medical Research Council Investigator Grant

Grant: GNT1176426

Medical Research Future Fund

Grant: MRF2023250

Medical Research Future Fund

Grant: MRF1170276

Medical Research Future Fund

Grant: MRF2007605

Medical Research Future Fund

Grant: MRF2024363

Medical Research Future Fund

Grant: MRF 1200254

Department of Defense

National Institutes of Health

Australian Government Research Training Program

Biogen

Steminent

Victorian Medical Research Accelerator Fund

Eisai

Multiple Sclerosis Australia

Department of Science Industry and Resources

goldLicense: cc-by

publisherhttps://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcaf022/61462134/fcaf022.pdf

publisherhttps://academic.oup.com/braincomms/article-pdf/7/1/fcaf022/61462134/fcaf022.pdf

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11775610/pdf/fcaf022.pdf

Europe_PMChttps://europepmc.org/articles/PMC11775610

Europe_PMChttps://europepmc.org/articles/PMC11775610?pdf=render

Keywords

Sample sizeBiomarkersClinical TrialDisease ProgressionProgressive Supranuclear Palsy

Biomarkers of disease progression in progressive supranuclear palsy for use in clinical trials

FAIR Checklist

Authors (4)

Funding (15 grants)

Open Access

Topics

Annotations (Europe PMC)